- Home
- CEE vs NKTR Comparison
CEE vs NKTR Comparison
Compare CEE & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEE
- NKTR
- Stock Information
- Founded
- CEE 1990
- NKTR 1990
- Country
- CEE Germany
- NKTR United States
- Employees
- CEE N/A
- NKTR N/A
- Industry
- CEE Finance Companies
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- CEE Finance
- NKTR Health Care
- Exchange
- CEE Nasdaq
- NKTR Nasdaq
- Market Cap
- CEE 97.8M
- NKTR 108.3M
- IPO Year
- CEE N/A
- NKTR 1994
- Fundamental
- Price
- CEE $15.55
- NKTR $25.32
- Analyst Decision
- CEE
- NKTR Strong Buy
- Analyst Count
- CEE 0
- NKTR 6
- Target Price
- CEE N/A
- NKTR $77.50
- AVG Volume (30 Days)
- CEE 22.0K
- NKTR 4.2M
- Earning Date
- CEE 01-01-0001
- NKTR 08-07-2025
- Dividend Yield
- CEE 3.86%
- NKTR N/A
- EPS Growth
- CEE N/A
- NKTR N/A
- EPS
- CEE N/A
- NKTR N/A
- Revenue
- CEE N/A
- NKTR $87,248,000.00
- Revenue This Year
- CEE N/A
- NKTR N/A
- Revenue Next Year
- CEE N/A
- NKTR N/A
- P/E Ratio
- CEE N/A
- NKTR N/A
- Revenue Growth
- CEE N/A
- NKTR N/A
- 52 Week Low
- CEE $7.80
- NKTR $6.48
- 52 Week High
- CEE $10.32
- NKTR $37.38
- Technical
- Relative Strength Index (RSI)
- CEE 53.53
- NKTR 72.72
- Support Level
- CEE $14.50
- NKTR $8.27
- Resistance Level
- CEE $15.42
- NKTR $37.38
- Average True Range (ATR)
- CEE 0.38
- NKTR 3.64
- MACD
- CEE -0.02
- NKTR 2.21
- Stochastic Oscillator
- CEE 83.84
- NKTR 60.46
About CEE The Central and Eastern Europe Fund Inc. (The)
CENTRAL & EASTERN EUROPE FUND, INC. is a closed-end management investment company. The Fund's objective is to seek long-term capital appreciation. It invests in the equity or equity-linked securities of issuers domiciled in Central and Eastern Europe.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.